Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001047469-04-006810
Filing Date
2004-03-05
Accepted
2004-03-05 17:15:13
Documents
8
Period of Report
2003-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a2129999z10-k.htm 10-K 632839
3 EX-10.27.2 a2129999zex-10_272.htm EX-10.27.2 62348
4 EX-10.36 a2129999zex-10_36.htm EX-10.36 41818
5 EXHIBIT 10.37 a2129999zex-10_37.txt EX-10.37 306189
6 EX-10.38 a2129999zex-10_38.htm EX-10.38 51418
7 EX-23.01 a2129999zex-23_01.htm EX-23.01 1641
8 EX-31.01 a2129999zex-31_01.htm EX-31.01 5322
9 EX-32.01 a2129999zex-32_01.htm EX-32.01 3477
  Complete submission text file 0001047469-04-006810.txt   1107404
Mailing Address 7000 NORTH BROADWAY SUITE 400 DENVER CO 80221
Business Address 11080 CIRCLEPOINT ROAD SUITE 200 WESTMINSTER CO 80020 3034266262
ALLOS THERAPEUTICS INC (Filer) CIK: 0001097264 (see all company filings)

EIN.: 541655029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-29815 | Film No.: 04652912
SIC: 2834 Pharmaceutical Preparations